Thoracic Aortic Aneurysm Clinical Trial
Official title:
Changes in Antibacterial Therapy Based on Perioperative Dynamics of Presepsin During Reconstructive Thoracic Aorta Surgery
According to the literature, presepsin was recommended not only as an effective indicator in the diagnosis of sepsis in intensive care units, but also as a reliable prognostic marker of postoperative inflammatory processes in cardiac surgery. Previous study carried out in Petrovsky NRCS related to biomarkers in cardiac surgery and presepsin in particular showed good sensitivity in infection complications prognosis.
Various biomarkers are being used to improve the quality of prediction models aiming to improve clinical outcomes and reduce mortality in the cardiac surgery patient population. In particular, presepsin and procalcitonin have comparable prognostic value for adverse renal, cardiovascular and respiratory outcomes in cardiac surgery patients. In addition, presepsin has in-hospital, 30-day, and 6-month prognostic mortality rate value and is also highly effective for the early diagnosis of sepsis in patients in the intensive care unit. In the previous study the absence of an increase in the level of presepsin in the first 6 hours after surgery was associated with an increased risk of developing a complicated course of the postoperative period (OR 4.15, 95% CI: 1.83-9.41). The combination of two risk factors - a presepsin level at the end of surgery >519.5 pg/ml and the absence of an increase in the presepsin level in the first 6 hours after surgery was associated with an increased risk of developing a complicated course of the postoperative period (OR 5.80, 95% CI: 2. 19-15.35). The hypothesis of this study suggests that in case of insufficient prevention of infectious complications, based on the dynamics of presepsin, it is permissible to administer the broad-spectrum drug ampicillin/sulbactam 3 g. every 6 hours for at least 72 hours from the date of surgery. It is expected that changes in the tactics of antibacterial therapy will reduce the number of inflammatory complications in patients undergoing surgery on thoracic aorta. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01390181 -
The Effect of Losartan in Bicuspid Aortic Valve Patients
|
N/A | |
Recruiting |
NCT00339053 -
Immunonutrition and Thoracoabdominal Aorta Aneurysm Repair
|
Phase 4 | |
Not yet recruiting |
NCT05395598 -
Incidence of Major Complication in Case of Thoracic Aortic Aneurysm
|
||
Recruiting |
NCT00549315 -
Clinical Study of Thoracic Aortic Aneurysm Exclusion
|
N/A | |
Recruiting |
NCT05777460 -
Mid- and Long-term Outcomes of Custom-made Aortic Devices
|
||
Active, not recruiting |
NCT05146375 -
Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)
|
||
Completed |
NCT01082172 -
South American Thoracic Stent-Graft Study
|
N/A | |
Recruiting |
NCT03824626 -
Biomechanical Reappraisal of Planning for Thoracic Endovascular Aortic Repair
|
||
Completed |
NCT04663074 -
Intravascular Ultrasound (IVUS) in Complex Aortic Endovascular Interventions
|
||
Recruiting |
NCT04747626 -
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
|
N/A | |
Active, not recruiting |
NCT05143138 -
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries
|
||
Completed |
NCT00111176 -
STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft
|
N/A | |
Recruiting |
NCT05639400 -
Thoraflex Hybrid and Relay Extension Post-Approval Study
|
||
Terminated |
NCT02735720 -
The CardiOvascular Remodeling Following Endovascular Aortic Repair (CORE) Study
|
||
Completed |
NCT02256163 -
Identification of Genes and Pathogenesis Involved in Familial Thoracic Aortic Aneurysm
|
N/A | |
Recruiting |
NCT06377033 -
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
|
N/A | |
Recruiting |
NCT06094127 -
Zenith Thoracic Alpha (ZTA) Post-Market Data Collection
|
||
Recruiting |
NCT03998631 -
Comparison of Carbon Dioxide and Saline Flush to Saline Flush in TEVAR and TAVI Procedures to Reduce Cerebral Ischemia
|
Phase 1 | |
Completed |
NCT05414318 -
CTAG Dissection/Trauma Post Marketing Surveillance Japan
|
||
Completed |
NCT04756778 -
Indexed Aortic Area in Bicuspid Aortic Valve Aortopathy
|